2011 Annual Meeting

Session: Integrated API and Drug Product Development

Chair

Ranjit Thakur, Novartis Pharma AG

Co-Chair

Michael B. Mackaplow, Abbott Laboratories

Presentations

08:30 AM

(32a) Correlating Powder Flowability to Particle Size Distribution Using Chemometric Techniques
Robert T. Roginski

08:50 AM

(32b) Optimization of API Attributes and Flow Properties Via Crystallization and Size Reduction Techniques
Plamen Grigorov, Azzeddine Lekhal, Dimitrios Zarkadas

09:10 AM

(32c) Crystallization and Milling Development Enabling A High Drug Load Formulation
Philip Hoffman, Jeffrey Vicenzi

09:30 AM

(32d) Analysis of Bayesian Linearity (BL) to Improve Performance for API to DP Integration
Dr. Albert Ivan Charles Einstiene

09:50 AM

(32e) API Particle Engineering As a Strategy to Address Sticking/Picking During Drug Product Development
Todd McDermott, Ahmad Sheikh, Jorge Gandarilla

10:10 AM

(32f) Utilizing Drop-On-Demand Printing In the Manufacture of Transdermal Dosage Forms
Marlena Brown

10:30 AM

(32g) API Excipient Co-Crystal Screen to Optimize Robustness of An Oral Solution Drug Product
Suman Luthra, Joseph Krzyzaniak, Brendan Murphy, Brian Samas